1. Home
  2. AIRS vs ABEO Comparison

AIRS vs ABEO Comparison

Compare AIRS & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$5.26

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.54

Market Cap

307.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRS
ABEO
Founded
2012
1974
Country
United States
United States
Employees
363
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.7M
307.5M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
AIRS
ABEO
Price
$5.26
$5.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$20.00
AVG Volume (30 Days)
1.4M
1.1M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.16
EPS
N/A
N/A
Revenue
$151,818,000.00
$2,998,000.00
Revenue This Year
$5.19
$1,024.31
Revenue Next Year
$5.32
$145.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
258.18
52 Week Low
$1.51
$4.00
52 Week High
$12.00
$7.54

Technical Indicators

Market Signals
Indicator
AIRS
ABEO
Relative Strength Index (RSI) 81.24 52.92
Support Level $2.40 $5.24
Resistance Level $6.90 $6.07
Average True Range (ATR) 0.43 0.31
MACD 0.13 -0.07
Stochastic Oscillator 100.00 48.40

Price Performance

Historical Comparison
AIRS
ABEO

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: